Luye Pharma Group (HK:2186) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Luye Pharma Group has successfully completed the issuance of US$100 million in convertible bonds at a 5.85% interest rate, due in 2025. This move aims to enhance the company’s liquidity and replace short-term loans, improving its debt maturity profile. The bonds are set to be listed on the Singapore Exchange on November 1, 2024.
For further insights into HK:2186 stock, check out TipRanks’ Stock Analysis page.
